Who
In numbers
- Trades disclosed
- 104
- Buys
- 0
- Sells
- 32
- Bought
- $0
- Sold
- $4.1M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 3 Dec 2019
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code G | —12,503 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code G | —12,503 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code G | —12,503 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code G | —12,503 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —1,530 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —1,530 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code G | —1,029 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code G | —1,029 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code G | —1,029 at $0.00 | filing |
| 19 May 2026filed 20 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code G | —1,029 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code M | $46K9,000 at $5.10 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $177K1,289 at $137.00 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $76K550 at $139.00 | filing |
| 4 May 2026filed 6 May 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $233K1,670 at $139.58 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $325K2,301 at $141.03 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $401K2,825 at $142.04 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $52K365 at $143.24 | filing |
| 4 May 2026filed 6 May 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code M | $46K9,000 at $5.10 | filing |
News
Celcuity Shares Climb Nearly 8% as Cantor Fitzgerald Backs Breast Cancer Drug Maker Ahead of Key ESMO DataCELC · ibtimes.com.au · 22 Oct 2026
0 headlines in the last 90 days name Richard E. Buller; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.